
Anker's new wireless earbuds come with a case that can also charge your phone
The new Soundcore P41i wireless earbuds are now available for purchase through the brand's online store in the UK for £89.99, or around $121. They're currently not listed on the US version of Soundcore's website, but previous versions of the earbuds in this line have seen a wider global release.
Anker says the earbuds themselves offer up to 12 hours of battery life with ANC turned off, which can be boosted to up to 192 hours when paired with the charging case. That's enough power to use the buds around the clock for eight continuous days, although with more realistic usage it means the case can probably go for about a month between charges.
That much battery life potentially makes the Soundcore P41i a great travel option, but also a solution for those dealing with smartphone battery anxiety. The charging case includes a built-in USB-C cable that doubles as a wrist strap, as well as a Lightning adapter for charging older iPhones and iPads. Anker estimates the case's 3,000mAh has enough capacity to charge a dead iPhone 16 Pro halfway, or a Samsung Galaxy S24 to 45 percent.
The Soundcore P41i earbuds feature 11mm composite drivers and the brand's optional BassUp technology for those wanting more presence from lower frequencies. They also offer adaptive ANC using six microphones with the option to adjust the intensity of the noise cancelling through Soundcore's app if you want to hear more of what's going on around you. AI noise reduction will help reduce background sounds while you're on a call, and the buds have an IPX5 water resistance rating so while getting them wet is okay, you'll want to avoid a complete dunking.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Respected manager retiring after long career at Inverclyde Trust
A RESPECTED manager is retiring after a long career at Inverclyde Community Development Trust. Bryan Graham has been described as a 'dedicated and hard-working manager' who was 'admired not only by his colleagues and staff but also by our volunteers, clients, and service users'. Bryan had worked with the trust for many years (Image: Inverclyde Community Development Trust) A spokesperson for the trust said: "Bryan's leadership has been instrumental in transforming our Port Glasgow workshops, and through his hard work, enthusiasm, and expertise, he has made a lasting difference to our community. "We extend our deepest gratitude and thanks to Bryan for his outstanding contribution to the trust. "While we will all miss Bryan, we are happy to see him step into a well-deserved retirement."
Yahoo
29 minutes ago
- Yahoo
Fugro First Half 2025 Earnings: Misses Expectations
Fugro (AMS:FUR) First Half 2025 Results Key Financial Results Revenue: €904.7m (down 17% from 1H 2024). Net loss: €18.3m (down by 116% from €112.5m profit in 1H 2024). €0.16 loss per share (down from €1.00 profit in 1H 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Fugro Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 7.3%. Earnings per share (EPS) was also behind analyst expectations. Looking ahead, revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Construction industry in Europe. Performance of the market in the Netherlands. The company's shares are down 10% from a week ago. Risk Analysis You should learn about the 2 warning signs we've spotted with Fugro. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
29 minutes ago
- Yahoo
CENIT Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
CENIT (ETR:CSH) Second Quarter 2025 Results Key Financial Results Revenue: €52.7m (up 8.0% from 2Q 2024). Net income: €145.0k (up 77% from 2Q 2024). Profit margin: 0.3% (up from 0.2% in 2Q 2024). EPS: €0.017 (up from €0.01 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period CENIT Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 6.3%. Earnings per share (EPS) missed analyst estimates by 79%. Looking ahead, revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Software industry in Germany. Performance of the German Software industry. The company's shares are down 3.3% from a week ago. Risk Analysis Don't forget that there may still be risks. For instance, we've identified 2 warning signs for CENIT (1 is a bit unpleasant) you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.